Back to Search
Start Over
PHASE 3 VALOR LYME DISEASE TRIAL: VALNEVA AND PFIZER ANNOUNCE PRIMARY VACCINATION SERIES COMPLETION
- Source :
- States News Service. July 17, 2024
- Publication Year :
- 2024
-
Abstract
- NEW YORK, N.Y.and Saint-Herblain (France) -- The following information was released by Pfizer Inc.: Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- States News Service
- Publication Type :
- News
- Accession number :
- edsgcl.801701329